myGwork - LGBTQ+ Business Community · 2 days ago
Head of Small Molecule and ASO Engineering
Wonder how qualified you are to the job?
Internet
Insider Connection @myGwork - LGBTQ+ Business Community
Responsibilities
Own strategic technical direction for all types of assets within the assigned subject matter area.
Develop intentional collaborations with external stakeholders and industry peers.
Serve as an innovation catalyst within Biogen by acquiring cutting edge knowledge in small molecule and ASO engineering.
Lead execution of small molecule and ASO engineering activities supporting capital projects.
Partner with site & external manufacturing to provide technical support and compliance oversight.
Oversee a team of small molecule, ASO, and industrial engineering professionals.
Qualification
Find out how your skills align with this job's requirements. If anything seems off, you can easily click on the tags to select or unselect skills to reflect your actual expertise.
Required
BS in Chemical Engineering or related process engineering discipline
A minimum of 15 years’ experience in Process Engineering in Biotech, Pharma or equivalent industry
Expert knowledge of small molecule and ASO modalities including asset lifecycle management practices within those modalities; specifically, engineering / facility best practices, reliability engineering, engineering document management, computerized maintenance management, and commissioning / qualification / validation
Expert knowledge and application of FDA and EMEA regulations
Advanced ability to influence individuals at both site and global level
Expert understanding of asset lifecycle data analytic concepts and methods
Preferred
MS or PhD in engineering discipline is strongly preferred but not required
Company
myGwork - LGBTQ+ Business Community
myGwork is the largest global platform for the LGBTQ+ business community.
Funding
Current Stage
Early StageTotal Funding
$4.77MKey Investors
24 HaymarketInnovate UK
2023-08-17Series Unknown· $1.66M
2023-08-17Grant· Undisclosed
2021-12-07Series A· $2.12M
Recent News
2024-04-10
Company data provided by crunchbase